Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Risinger, MD
BioXcel Therapeutics
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bioxcel Clinical Research Site
Phoenix, Arizona, United States
- Bioxcel Clinical Research Site
Long Beach, California, United States
- Bioxcel Clinical Research Site
Daytona Beach, Florida, United States
- Bioxcel Clinical Research Site
Lady Lake, Florida, United States
- Bioxcel Clinical Research Site
Maitland, Florida, United States
- Bioxcel Clinical Research Site
Miami Lakes, Florida, United States
- Bioxcel Clinical Research Site
North Miami, Florida, United States
- Bioxcel Clinical Research Site
Marrero, Louisiana, United States
- Bioxcel Clinical Research Site
Springfield, Massachusetts, United States
- Bioxcel Clinical Research Site
Berlin, New Jersey, United States
- Bioxcel Clinical Research Site
Toms River, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Apr 2022
- Primary completion
- 21 Apr 2023
- Completion
- 21 Apr 2023
- Last update posted
- 31 Dec 2025
- Registered enrollment
- 151
- Registry id
- NCT05271552
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.